Health
FDA Approves First RSV Vaccine for Pregnant Individuals to Protect Infants
Trevor Sandoval
Landmark Approval Aims to Shield Infants from RSV at Birth On August 21, 2023, the U.S. Food and Drug Administration (FDA) approved Abrysvo, the first-ever respiratory syncytial virus (RSV) vaccine…
Continue Reading4 years ago
